Virtus ETF Advisers LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 132 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$397,000
+21.8%
65,813
-27.3%
0.06%
-1.5%
Q3 2019$326,000
+27.3%
90,554
-5.3%
0.07%
+22.2%
Q2 2019$256,000
-0.4%
95,598
+10.0%
0.05%
-90.1%
Q1 2019$257,000
+69.1%
86,904
-9.3%
0.55%
+2003.8%
Q4 2018$152,000
-73.9%
95,817
-39.5%
0.03%
-56.7%
Q3 2018$582,000
-24.2%
158,277
-41.7%
0.06%
-91.2%
Q2 2018$768,000
-21.1%
271,426
+3.5%
0.68%
-19.5%
Q1 2018$973,000
+178.8%
262,284
+116.3%
0.84%
+92.7%
Q4 2017$349,000
+0.3%
121,264
+56.6%
0.44%
+831.9%
Q3 2017$348,000
+7.7%
77,433
+10.1%
0.05%
-2.1%
Q2 2017$323,000
+10.6%
70,350
+1.3%
0.05%
-7.7%
Q1 2017$292,000
+12.7%
69,450
+10.6%
0.05%
-32.5%
Q4 2016$259,000
+18.8%
62,792
+133.3%
0.08%
-26.7%
Q3 2016$218,000
+3.8%
26,9150.0%0.10%
-32.7%
Q2 2016$210,000
+6.1%
26,915
+4.7%
0.16%
-42.9%
Q1 2016$198,00025,7110.27%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$57,396,0007.04%
HealthInvest Partners AB 497,807$2,096,0003.21%
BVF INC/IL 3,285,400$13,832,0002.35%
EMORY UNIVERSITY 486,438$2,048,0001.93%
Marcus Capital, LLC 69,400$1,751,0001.63%
DAFNA Capital Management LLC 196,500$827,0000.70%
Orbimed Advisors 13,107,200$55,181,0000.62%
Rock Springs Capital Management LP 1,500,000$6,315,0000.36%
Spark Investment Management LLC 710,100$2,989,0000.19%
TURNER INVESTMENTS LLC 65,420$275,0000.18%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders